Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anatol Kontush

Showing results (71-80 of 135) with videos related to

Pageof 14
Sort By:
Journal of Clinical Lipidology|August 23, 2017
Paradoxical coronary artery disease in humans with hyperalphalipoproteinemia is associated with distinct differences in the high-density lipoprotein phosphosphingolipidomeWilliam Hancock-Cerutti, Marie Lhomme, Carolane Dauteuille, et al.
Antioxidants (Basel, Switzerland)|August 26, 2023
Abnormal Lipoproteins Trigger Oxidative Stress-Mediated Apoptosis of Renal Cells in LCAT DeficiencyMonica Gomaraschi, Marta Turri, Arianna Strazzella, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|June 25, 2011
Blood pressure-lowering response to amlodipine as a determinant of the antioxidative activity of small, dense HDL3Boris Hansel, Xavier Girerd, Dominique Bonnefont-Rousselot, et al.
Archives of Medical Science : AMS|February 23, 2023
Compositional and functional properties of high-density lipoproteins in relation to coronary in-stent restenosisShiva Ganjali, Elahe Mahdipour, Seyed Hamid Aghaee-Bakhtiari, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|June 16, 2007
Preferential sphingosine-1-phosphate enrichment and sphingomyelin depletion are key features of small dense HDL3 particles: relevance to antiapoptotic and antioxidative activitiesAnatol Kontush, Patrice Therond, Amal Zerrad, et al.
Atherosclerosis|June 8, 2002
Comparison of the effects of alpha-tocopherol, ubiquinone-10 and probucol at therapeutic doses on atherosclerosis in WHHL rabbitsJan Hinrich Bräsen, Kai Koenig, Heiko Bach, et al.
American Journal of Cardiovascular Disease|November 23, 2020
Comparative analysis of the variability of carotid intima-media thickness in primary prevention populations of Moscow and ParisTatiana V Kirichenko, Ekaterina V Chernova, Yegor S Chegodaev, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 5, 2013
Small, dense high-density lipoprotein-3 particles are enriched in negatively charged phospholipids: relevance to cellular cholesterol efflux, antioxidative, antithrombotic, anti-inflammatory, and antiapoptotic functionalitiesLaurent Camont, Marie Lhomme, Fabiana Rached, et al.
Cardiovascular Drugs and Therapy|February 20, 2019
HDL-Targeted Therapies During Myocardial InfarctionAndrei C Sposito, Helison R Carmo, Joaquim Barreto, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|November 23, 2019
Antiatherogenic properties of high-density lipoproteins from arterial plasma are attenuated as compared to their counterparts of venous originDominique Bonnefont-Rousselot, Leila Benouda, Randa Bittar, et al.
Pageof 14

Showing results (71-80 of 135) with videos related to

Sort By:
Pageof 14
Journal of Clinical Lipidology|August 23, 2017
Paradoxical coronary artery disease in humans with hyperalphalipoproteinemia is associated with distinct differences in the high-density lipoprotein phosphosphingolipidomeWilliam Hancock-Cerutti, Marie Lhomme, Carolane Dauteuille, et al.
Antioxidants (Basel, Switzerland)|August 26, 2023
Abnormal Lipoproteins Trigger Oxidative Stress-Mediated Apoptosis of Renal Cells in LCAT DeficiencyMonica Gomaraschi, Marta Turri, Arianna Strazzella, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|June 25, 2011
Blood pressure-lowering response to amlodipine as a determinant of the antioxidative activity of small, dense HDL3Boris Hansel, Xavier Girerd, Dominique Bonnefont-Rousselot, et al.
Archives of Medical Science : AMS|February 23, 2023
Compositional and functional properties of high-density lipoproteins in relation to coronary in-stent restenosisShiva Ganjali, Elahe Mahdipour, Seyed Hamid Aghaee-Bakhtiari, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|June 16, 2007
Preferential sphingosine-1-phosphate enrichment and sphingomyelin depletion are key features of small dense HDL3 particles: relevance to antiapoptotic and antioxidative activitiesAnatol Kontush, Patrice Therond, Amal Zerrad, et al.
Atherosclerosis|June 8, 2002
Comparison of the effects of alpha-tocopherol, ubiquinone-10 and probucol at therapeutic doses on atherosclerosis in WHHL rabbitsJan Hinrich Bräsen, Kai Koenig, Heiko Bach, et al.
American Journal of Cardiovascular Disease|November 23, 2020
Comparative analysis of the variability of carotid intima-media thickness in primary prevention populations of Moscow and ParisTatiana V Kirichenko, Ekaterina V Chernova, Yegor S Chegodaev, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 5, 2013
Small, dense high-density lipoprotein-3 particles are enriched in negatively charged phospholipids: relevance to cellular cholesterol efflux, antioxidative, antithrombotic, anti-inflammatory, and antiapoptotic functionalitiesLaurent Camont, Marie Lhomme, Fabiana Rached, et al.
Cardiovascular Drugs and Therapy|February 20, 2019
HDL-Targeted Therapies During Myocardial InfarctionAndrei C Sposito, Helison R Carmo, Joaquim Barreto, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|November 23, 2019
Antiatherogenic properties of high-density lipoproteins from arterial plasma are attenuated as compared to their counterparts of venous originDominique Bonnefont-Rousselot, Leila Benouda, Randa Bittar, et al.
Pageof 14